Refine
Document Type
- Article (6)
- Part of Periodical (1)
Language
- English (7)
Has Fulltext
- yes (7)
Is part of the Bibliography
- no (7)
Keywords
- SARS-CoV-2 (2)
- 5′-UTR (1)
- Air traffic (1)
- COVID19-NMR (1)
- Covid19-nmr (1)
- Desinfektion von Flugzeugen (1)
- Disinfection of aircraft (1)
- Highly infectious diseases (1)
- Hochansteckende Krankheiten (1)
- Luftverkehr (1)
- NMR spectroscopy (1)
- Produkte zur Desinfektion (1)
- RNA (1)
- SL5b (1)
- SL5b + c (1)
- SL5c (1)
- Solution NMR spectroscopy (1)
- Standardized operating procedures (1)
- Standardverfahren (1)
- Substances for disinfection (1)
- Taxonomy (1)
- anaesthesia in orthopaedics (1)
- anaesthetics (1)
- first description (1)
- fragment screening (1)
- geriatric medicine (1)
- key to species (1)
- range extensions (1)
- subtropical to tropical West Atlantic (1)
Institute
Introduction: Hip fracture surgery is associated with high in-hospital and 30-day mortality rates and serious adverse patient outcomes. Evidence from randomised controlled trials regarding effectiveness of spinal versus general anaesthesia on patient-centred outcomes after hip fracture surgery is sparse.
Methods and analysis: The iHOPE study is a pragmatic national, multicentre, randomised controlled, open-label clinical trial with a two-arm parallel group design. In total, 1032 patients with hip fracture (>65 years) will be randomised in an intended 1:1 allocation ratio to receive spinal anaesthesia (n=516) or general anaesthesia (n=516). Outcome assessment will occur in a blinded manner after hospital discharge and inhospital. The primary endpoint will be assessed by telephone interview and comprises the time to the first occurring event of the binary composite outcome of all-cause mortality or new-onset serious cardiac and pulmonary complications within 30 postoperative days. In-hospital secondary endpoints, assessed via in-person interviews and medical record review, include mortality, perioperative adverse events, delirium, satisfaction, walking independently, length of hospital stay and discharge destination. Telephone interviews will be performed for long-term endpoints (all-cause mortality, independence in walking, chronic pain, ability to return home cognitive function and overall health and disability) at postoperative day 30±3, 180±45 and 365±60.
Ethics and dissemination: iHOPE has been approved by the leading Ethics Committee of the Medical Faculty of the RWTH Aachen University on 14 March 2018 (EK 022/18). Approval from all other involved local Ethical Committees was subsequently requested and obtained. Study started in April 2018 with a total recruitment period of 24 months. iHOPE will be disseminated via presentations at national and international scientific meetings or conferences and publication in peer-reviewed international scientific journals.
Trial registration number: DRKS00013644; Pre-results
Revised definitions are given for the genus Mysidium Dana, 1852, and its eight previously known species, based on material from Curaçao, Bonaire and SE-Brazil, along with the evaluation of published data. Type material of Diamysis columbiae Zimmer, 1915, M. cubanense Băcescu & Ortiz, 1984 and M. rubroculatum Băcescu & Ortiz, 1984 is examined. A lectotype is designated for D. columbiae Zimmer, 1915, a senior synonym of Mysidium columbiae (Zimmer, 1915). Two new species are described, M. triangulare Wittmann sp. nov. from Curaçao and M. antillarum Wittmann sp. nov. from Curaçao and Bonaire. Known ranges are extended by first records of M. cubanense from Curaçao and Bonaire and of M. integrum W.M. Tattersall, 1951 from SE Brazil. Three morphologically different groups are established at the subgeneric level: (1) the nominotypical subgenus Mysidium Dana, 1852 with M. gracile (Dana, 1852), M. integrum, M. cubanense, M. rubroculatum and M. triangulare sp. nov. from the West Atlantic plus M. rickettsi Harrison & Bowman, 1987 from the East Pacific; (2) Occimysidium Wittmann subgen. nov. represented only by M. pumae Ortiz, Hendrickx & Winfield, 2017 from the Pacific coast of Mexico; and finally (3) Orientomysidium Wittmann subgen. nov. comprising M. columbiae and M. antillarum sp. nov. from the West Atlantic. The poorly known M. iliffei Băcescu, 1991 is not assigned to any subgenus. A key to the resulting three subgenera and ten nominal species of the genus Mysidium is given.
SARS-CoV-2 contains a positive single-stranded RNA genome of approximately 30 000 nucleotides. Within this genome, 15 RNA elements were identified as conserved between SARS-CoV and SARS-CoV-2. By nuclear magnetic resonance (NMR) spectroscopy, we previously determined that these elements fold independently, in line with data from in vivo and ex-vivo structural probing experiments. These elements contain non-base-paired regions that potentially harbor ligand-binding pockets. Here, we performed an NMR-based screening of a poised fragment library of 768 compounds for binding to these RNAs, employing three different 1H-based 1D NMR binding assays. The screening identified common as well as RNA-element specific hits. The results allow selection of the most promising of the 15 RNA elements as putative drug targets. Based on the identified hits, we derive key functional units and groups in ligands for effective targeting of the RNA of SARS-CoV-2.
The current pandemic situation caused by the Betacoronavirus SARS-CoV-2 (SCoV2) highlights the need for coordinated research to combat COVID-19. A particularly important aspect is the development of medication. In addition to viral proteins, structured RNA elements represent a potent alternative as drug targets. The search for drugs that target RNA requires their high-resolution structural characterization. Using nuclear magnetic resonance (NMR) spectroscopy, a worldwide consortium of NMR researchers aims to characterize potential RNA drug targets of SCoV2. Here, we report the characterization of 15 conserved RNA elements located at the 5′ end, the ribosomal frameshift segment and the 3′-untranslated region (3′-UTR) of the SCoV2 genome, their large-scale production and NMR-based secondary structure determination. The NMR data are corroborated with secondary structure probing by DMS footprinting experiments. The close agreement of NMR secondary structure determination of isolated RNA elements with DMS footprinting and NMR performed on larger RNA regions shows that the secondary structure elements fold independently. The NMR data reported here provide the basis for NMR investigations of RNA function, RNA interactions with viral and host proteins and screening campaigns to identify potential RNA binders for pharmaceutical intervention.
1H, 13C and 15N chemical shift assignment of the stem-loops 5b + c from the 5′-UTR of SARS-CoV-2
(2022)
The ongoing pandemic of the respiratory disease COVID-19 is caused by the SARS-CoV-2 (SCoV2) virus. SCoV2 is a member of the Betacoronavirus genus. The 30 kb positive sense, single stranded RNA genome of SCoV2 features 5′- and 3′-genomic ends that are highly conserved among Betacoronaviruses. These genomic ends contain structured cis-acting RNA elements, which are involved in the regulation of viral replication and translation. Structural information about these potential antiviral drug targets supports the development of novel classes of therapeutics against COVID-19. The highly conserved branched stem-loop 5 (SL5) found within the 5′-untranslated region (5′-UTR) consists of a basal stem and three stem-loops, namely SL5a, SL5b and SL5c. Both, SL5a and SL5b feature a 5′-UUUCGU-3′ hexaloop that is also found among Alphacoronaviruses. Here, we report the extensive 1H, 13C and 15N resonance assignment of the 37 nucleotides (nts) long sequence spanning SL5b and SL5c (SL5b + c), as basis for further in-depth structural studies by solution NMR spectroscopy.
For infectious diseases caused by highly pathogenic agents (e. g., Ebola/Lassa fever virus, SARS-/MERS-CoV, pandemic influenza virus) which have the potential to spread over several continents within only a few days, international Health Protection Authorities have taken appropriate measures to limit the consequences of a possible spread. A crucial point in this context is the disinfection of an aircraft that had a passenger on board who is suspected of being infected with one of the mentioned diseases. Although, basic advice on hygiene and sanitation on board an aircraft is given by the World Health Organization, these guidelines lack details on available and effective substances as well as standardized operating procedures (SOP). The purpose of this paper is to give guidance on the choice of substances that were tested by a laboratory of Lufthansa Technik and found compatible with aircraft components, as well as to describe procedures which ensure a safe and efficient disinfection of civil aircrafts. This guidance and the additional SOPs are made public and are available as mentioned in this paper.